Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-04-06
1993-07-27
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514253, 514258, 544117, 544118, 544263, 544281, 544309, 544320, 548253, 558303, 560179, C07D48704
Patent
active
052310949
ABSTRACT:
The present invention relates to the derivatives of the formula ##STR1## and their tautomeric forms, as well as their addition salts, and to their use in therapeutics, especially for the treatment of cardiovascular diseases and in particular for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall.
REFERENCES:
patent: 4483987 (1984-11-01), Wagner et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4576943 (1988-03-01), Tomcufcik
patent: 4895850 (1990-01-01), Gesing
patent: 5100897 (1992-03-01), Allen et al.
patent: 5102880 (1992-04-01), Chakravarty et al.
patent: 5127936 (1992-06-01), Selby
Herold et al. Chem. Abst. vol. 115, Entry 159173y (1991) abstracting EP 435827.
Herold et al. Chem. Abst. vol. 114 Entry 247301y (1991) abstracting EP407342.
Bru-Magniez Nicole
Gungor Timur
Teulon Jean-Marie
Daus Donald G.
Societe Anonyme: Laboratoires UPSA
LandOfFree
Triazolopyrimidines which are angiotensin II receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolopyrimidines which are angiotensin II receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopyrimidines which are angiotensin II receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2342400